Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
News|Articles|July 2, 2021
- Pharmaceutical Technology, July 2021 Issue
- Volume 45
- Issue 7
Ergonomic Sanitary Ribbon Blenders
ROSS’ Sanitary Ribbon Blenders allow operators to safely empty bags of powder through a bar grating while a contiguous vibrating tray assembly catches debris and off-spec ingredients.
ROSS’ Sanitary Ribbon Blenders with ergonomic material handling accessories feature a new design that allows operators to safely empty bags of powder through a bar grating while a contiguous vibrating tray assembly catches debris and off-spec ingredients. Now available on all Ribbon Blenders, including the Model 42N-18SS (pictured), the new design uses safety limit switches to prevent operation of the agitator if access ports are open or if the grating is removed.
Additionally, the blenders come equipped with a sanitary 4-inch spherical disc discharge valve with a pneumatic actuator and UL-listed operator controls in a NEMA 4X stainless steel enclosure with 3R fan shrouds, variable frequency drive, digital speed and amperage readouts, dial-type potentiometer, cycle timer, and E-Stop. All interior and exterior surfaces of the blenders are stainless steel, polished to 150-grit sanitary finish.
Articles in this issue
over 5 years ago
Complex Biomolecules Require Analytical Evolutionover 5 years ago
Meeting Future Analytical Requirements for Novel Biotherapeuticsover 5 years ago
Subunit Vaccines and the Fight Against COVID-19over 5 years ago
Formulating Tablets Layer by Layerover 5 years ago
Innovations Meet Growing Demand for Prefilled Syringesover 5 years ago
Survey of QPs on Remote Certificationover 5 years ago
Assessing Legacy Drug Qualityover 5 years ago
Considering Annex 1 Revisions: Expert InsightsRelated to this article
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
How to test pen injector assembly interfaces from URS to FAT and SAT: verify part tracking, reject confirmation, restarts, and data transfer evidence.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
Trending on Pharmaceutical Technology
1
Pharma Leaders Weigh in On AI's Measurable Results In 2026
2
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
3
Manufacturing Intelligence: How AI Poisoning Hides in Plain Sight
4
Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities
5